(Q35928615)

11 August 2017

The prediction of adverse maternal outcomes in preeclampsia (English)

1 reference

11 August 2017

The Prediction of Adverse Maternal Outcomes in Preeclampsia (English)

0 references

0 references

0 references

1

Peter von Dadelszen

1 reference

11 August 2017

9

Andrée Gruslin

1 reference

11 August 2017

2

Laura A Magee

1 reference

11 August 2017

2

Laura A. Magee

0 references

Shoo K Lee

11

Shoo K Lee

1 reference

11 August 2017

11

Shoo K. Lee

0 references

Keith R Walley

8

Keith R Walley

1 reference

11 August 2017

Rajashree M. Devarakonda

3

Rajashree M Devarakonda

1 reference

11 August 2017

Rajashree M. Devarakonda

3

Rajashree M. Devarakonda

0 references

Trevor Hamilton

4

Trevor Hamilton

1 reference

11 August 2017

6

Ruihua Yin

1 reference

11 August 2017

10

Jean-Marie Moutquin

1 reference

11 August 2017

Laurie M Ainsworth

5

1 reference

11 August 2017

Monica Norena

7

1 reference

11 August 2017

James A Russell

12

1 reference

11 August 2017

Laurie M. Ainsworth

5

0 references

James A. Russell

12

0 references

publication date

1 October 2004

1 reference

Journal of Obstetrics and Gynaecology Canada

11 August 2017

October 2004

0 references

published in

1 reference

11 August 2017

26

1 reference

11 August 2017

871-879

1 reference

11 August 2017

10

1 reference

Pre-eclampsia: more than pregnancy-induced hypertension

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Fortnightly review: management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

1 reference

7 January 2021

Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Management of severe, early pre-eclampsia: is conservative management justified?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

The detection, investigation and management of hypertension in pregnancy: full consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Eclampsia in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Subclassification of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Platelets and the beginnings of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Early platelet consumption in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Can platelet volume predict progressive hypertensive disease in pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Preeclampsia: an excessive maternal inflammatory response to pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Medical Assessment by a Delphi Group Opinion Technic

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Scoring systems for eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

Intensive care unit morbidity and mortality from eclampsia: an evaluation of the Acute Physiology and Chronic Health Evaluation II score and the Glasgow Coma Scale score

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930137-2

7 January 2021

10.1016/S1701-2163(16)30137-2

Identifiers

DOI

0 references

1 reference